1 Introduction The socioeconomic and medical severity of alcohol use disorder (AUD) is substantial (Rehm et al., 2009), and the limited efficacy of available treatments is thus a major concern (Soderpalm et al., 2020
With expert guidance and support, GLP-1 can be a game-changer in your journey toward a healthier, happier you
The latest results come from SURPASS-2, which included an additional 1,879 participants with type 2 diabetes who injected weekly doses of tirzepatide or semaglutide, the current "state of the art" GLP-1 agonist
Hirobe, 2014
Headache: Occasional, usually mild
Obesity (Silver Spring), 30(6), 10401051